Page last updated: 2024-08-20

yohimbine and Lung Injury, Ventilator-Induced

yohimbine has been researched along with Lung Injury, Ventilator-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; Hou, Y; Liu, D; Sun, X; Wang, H; Wang, Y; Wu, J; Yang, X; Yi, W; Yu, J; Yu, X	1

Other Studies

1 other study(ies) available for yohimbine and Lung Injury, Ventilator-Induced

Article	Year
Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Bosnian journal of basic medical sciences, 2018, May-20, Volume: 18, Issue:2 Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Humans; Inflammation; Lung; Male; NF-kappa B; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Signal Transduction; Toll-Like Receptor 4; Ventilator-Induced Lung Injury; Yohimbine	2018

Article

Year

Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.

Bosnian journal of basic medical sciences, 2018, May-20, Volume: 18, Issue:2

Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Humans; Inflammation; Lung; Male; NF-kappa B; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Signal Transduction; Toll-Like Receptor 4; Ventilator-Induced Lung Injury; Yohimbine

2018